Newswires
No comments
Financial Results 2022 Financial Supplement (preliminary figures)
German Equity Markets (Web Disclosure) via PUBT
Key figures
Key figures | |||||||
Q1-4 2022 | Q1-4 2021 | Change | Q4 2022 | Q4 2021 | Change | ||
% | % | ||||||
Consolidated result | €m | 3,419 | 2,932 | 16.6 | 1,516 | 871 | 74.0 |
Thereof attributable to non-controlling interests | €m | -13 | -1 | <-1.000,0 | -11 | 3 | - |
Earnings per share | € | 24.63 | 20.93 | 17.6 | 11.05 | 6.20 | 78.3 |
Retuon equity (RoE) | % | 13.5 | 12.6 | 23.6 | 14.7 | ||
Retuon investment (Rol) | % | 2.1 | 2.8 | 3.6 | 2.2 | ||
Change | |||||||
% | |||||||
Share price | € | 304.00 | 260.50 | 16.7 | |||
€bn | 42.6 | 36.5 | 16.7 | ||||
Carrying amount per share | € | 153.02 | 220.06 | -30.5 | |||
Investments | €m | 219,797 | 240,300 | -8.5 | |||
Insurance-related investments | €m | 11,128 | 12,283 | -9.4 | |||
Equity | €m | 21,202 | 30,945 | -31.5 | |||
Off-balance-sheet unrealised gains and losses1 | €m | 5,494 | 18,888 | -70.9 | |||
Net technical provisions | €m | 232,456 | 234,044 | -0.7 | |||
Balance sheet total | €m | 298,570 | 312,405 | -4.4 | |||
Solvency II ratio | % | 260 | 227 | ||||
Number of staff | 41,389 | 39,281 | 5.4 | ||||
1 Including those apportionable to minority interests and policyholders. | |||||||
Reinsurance | Q1-4 2022 | Q1-4 2021 | Change | Q4 2022 | Q4 2021 | Change | |
% | % | ||||||
Gross premiums written | €m | 48,075 | 41,354 | 16.3 | 11,717 | 10,506 | 11.5 |
Combined ratio property-casualty | % | 96.2 | 99.6 | 94.4 | 96.4 | ||
Investment result | €m | 1,520 | 3,422 | -55.6 | 1,432 | 893 | 60.4 |
Consolidated result | €m | 2,593 | 2,328 | 11.4 | 1,393 | 734 | 89.8 |
Thereof: Reinsurance - Life and health | €m | 737 | 325 | 127.1 | 245 | 86 | 185.9 |
Thereof: Reinsurance - Property-casualty | €m | 1,856 | 2,003 | -7.3 | 1,148 | 648 | 77.0 |
Retuon equity (RoE) | % | 13.8 | 13.4 | 29.9 | 16.6 | ||
ERGO | Q1-4 2022 | Q1-4 2021 | Change | Q4 2022 | Q4 2021 | Change | |
% | % | ||||||
Gross premiums written | €m | 19,058 | 18,213 | 4.6 | 4,506 | 4,388 | 2.7 |
Combined ratio Property-casualty |
% | 90.6 | 92.4 | 91.4 | 87.6 | ||
Combined ratio International | % | 94.3 | 92.9 | 96.1 | 93.1 | ||
Investment result | €m | 3,383 | 3,734 | -9.4 | 610 | 532 | 14.5 |
Consolidated result | €m | 826 | 605 | 36.6 | 124 | 137 | -10.0 |
Thereof: Life and Health Germany | €m | 485 | 164 | 196.5 | 38 | -42 | - |
Thereof: Property-casualty |
€m | 185 | 234 | -20.7 | 62 | 106 | -41.7 |
Thereof: International | €m | 155 | 207 | -25.0 | 24 | 73 | -67.3 |
Retuon equity (RoE) | % | 12.5 | 10.1 | 6.9 | 9.2 |
Outlook
Outlook |
||
2023 | ||
Insurance revenue (gross) | €bn | 58 |
Total technical result - Life and health reinsurance | €bn | 1 |
Combined ratio - Property-casualty reinsurance | % | 86 |
Combined ratio - ERGO Property-casualty |
% | 89 |
Combined ratio - ERGO International | % | 90 |
Retuon investment1 | % | Over 2.2 |
Consolidated result | €bn | 4.0 |
Economic Earnings | €bn | Over 4.0 |
1 Excluding insurance-related investments. |
Investment mix
Investment mix | ||||||
Unrealised | ||||||
€m | Carrying amounts | gains/losses1 | Fair values | |||
Land and buildings, including buildings on third-party land | 7,340 | 7,029 | 5,753 | 6,291 | 13,092 | 13,320 |
Investments in affiliated companies, associates and joint ventures | 5,904 | 3,635 | 3,036 | 2,812 | 8,782 | 6,258 |
Loans | 48,547 | 50,389 | -4,956 | 8,270 | 43,591 | 58,659 |
Other securities available for sale | 140,388 | 162,468 | -13,065 | 12,967 | 140,388 | 162,468 |
Thereof: Fixed-interest | 121,581 | 138,209 | -15,015 | 8,078 | 121,581 | 138,209 |
Thereof: Non-fixed-interest | 18,807 | 24,259 | 1,950 | 4,888 | 18,807 | 24,259 |
Other securities at fair value through profit or loss | 3,956 | 2,950 | 3,956 | 2,950 | ||
Thereof: Derivatives | 1,974 | 1,718 | 1,974 | 1,718 | ||
Deposits retained on assumed reinsurance | 9,494 | 9,027 | 9,494 | 9,027 | ||
Other investments | 4,168 | 4,803 | 4,168 | 4,803 | ||
Total | 219,797 | 240,300 | -9,233 | 30,340 | 223,471 | 257,485 |
1 Including on- and off-balance-sheet unrealised gains and losses. |
Investment Result
Investment result | ||||||
Q1-4 2022 | RoI1 | Q1-4 2021 | RoI1 | Q4 2022 | Q4 2021 | |
€m | % | €m | % | €m | €m | |
Regular income | 6,565 | 2.8 | 6,017 | 2.4 | 1,712 | 1,437 |
Write-ups/write-downs of non-derivative investments | -3,155 | -1.3 | -505 | -0.2 | -211 | -88 |
Gains/losses on the disposal of non-derivative investments | 3,962 | 1.7 | 3,182 | 1.3 | 1,528 | 691 |
Net balance of derivatives | -1,629 | -0.7 | -774 | -0.3 | -748 | -377 |
Other income/expenses | -839 | -0.4 | -764 | -0.3 | -239 | -238 |
Total | 4,903 | 2.1 | 7,156 | 2.8 | 2,041 | 1,425 |
1 Annual % retuon the mean value of the investment portfolio (RoI) measured at market value as at the quarterly reporting dates. The overall investment portfolio used to determine the retufor 2022 (2.1%) was calculated as the mean value of the investment portfolios (carrying amounts) as at |
Balance sheet
Consolidated balance sheet | |||||
Assets | |||||
Change | |||||
€m | €m | €m | €m | €m | % |
A. | Intangible assets | ||||
I. | 3,240 | 3,092 | 148 | 4.8 | |
II. | Other intangible assets | 1,297 | 1,286 | 10 | 0.8 |
4,537 | 4,379 | 158 | 3.6 | ||
B. | Investments | ||||
I. | Land and buildings, including buildings | ||||
on third-party land | 7,340 | 7,029 | 311 | 4.4 | |
II. | Investments in affiliated companies, | ||||
associates and | |||||
joint ventures | 5,904 | 3,635 | 2,269 | 62.4 | |
Thereof: | |||||
Associates and joint | |||||
ventures accounted for | |||||
using the equity method | 5,449 | 3,215 | 2,234 | 69.5 | |
III. | Loans | 48,547 | 50,389 | -1,842 | -3.7 |
IV. | Other securities | ||||
1. Available for sale | 140,388 | 162,468 | -22,080 | -13.6 | |
2. At fair value through profit or loss | 3,956 | 2,950 | 1,007 | 34.1 | |
144,345 | 165,418 | -21,073 | -12.7 | ||
V. | Deposits retained on assumed reinsurance | 9,494 | 9,027 | 466 | 5.2 |
VI. | Other investments | 4,168 | 4,803 | -635 | -13.2 |
219,797 | 240,300 | -20,503 | -8.5 | ||
C. | Insurance-related investments | 11,128 | 12,283 | -1,155 | -9.4 |
D. | Ceded share of technical provisions | 6,498 | 6,099 | 399 | 6.5 |
E. | Receivables | ||||
I. | Current tax receivables | 695 | 715 | -21 | -2.9 |
II. | Other receivables | 32,749 | 29,058 | 3,692 | 12.7 |
33,444 | 29,773 | 3,671 | 12.3 | ||
F. | Cash at banks, cheques and cash in hand | 6,439 | 5,413 | 1,026 | 19.0 |
G. | Deferred acquisition costs | ||||
Gross | 11,089 | 10,545 | 545 | 5.2 | |
Ceded share | -664 | -608 | -56 | -9.2 | |
Net | 10,425 | 9,937 | 488 | 4.9 | |
H. | Deferred tax assets | 2,775 | 503 | 2,272 | 451.4 |
I. | Other assets | 3,080 | 3,167 | -87 | -2.7 |
J. | Non-current assets held for sale | 448 | 552 | -104 | -18.9 |
Total assets | 298,570 | 312,405 | -13,834 | -4.4 | |
Equity and liabilities | |||||
Change | |||||
€m | €m | €m | €m | % | |
A. | Equity | ||||
I. | Issued capital and capital reserve | 7,422 | 7,432 | -10 | -0.1 |
II. | Revenue reserves | 15,414 | 13,822 | 1,592 | 11.5 |
III. | Other reserves | -5,205 | 6,642 | -11,848 | - |
IV. | Consolidated result attributable | ||||
to |
3,432 | 2,933 | 499 | 17.0 | |
V. | Non-controlling interests | 139 | 116 | 24 | 20.4 |
21,202 | 30,945 | -9,743 | -31.5 | ||
B. | Subordinated liabilities | 4,748 | 5,055 | -307 | -6.1 |
C. | Gross underwriting provisions | ||||
I. | Unearned premiums | 14,510 | 13,474 | 1,036 | 7.7 |
II. | Provision for future policy benefits | 115,663 | 114,586 | 1,077 | 0.9 |
III. | Provision for outstanding claims | 89,438 | 81,671 | 7,767 | 9.5 |
IV. | Other underwriting provisions | 11,563 | 21,414 | -9,851 | -46.0 |
231,173 | 231,145 | 29 | 0.0 | ||
D. | Gross technical provisions | ||||
for unit-linked life insurance | 7,780 | 8,998 | -1,219 | -13.5 | |
E. | Other provisions | 2,661 | 4,958 | -2,297 | -46.3 |
F. | Liabilities | ||||
I. | Notes and debentures | 300 | 293 | 7 | 2.4 |
II. | Deposits retained on ceded business | 1,106 | 1,502 | -396 | -26.4 |
III. | Current tax liabilities | 1,569 | 1,845 | -277 | -15.0 |
IV. | Other liabilities | 27,681 | 26,069 | 1,613 | 6.2 |
30,656 | 29,709 | 947 | 3.2 | ||
G. | Deferred tax liabilities | 136 | 1,300 | -1,164 | -89.5 |
H. | Liabilities related to | ||||
non-current assets held for sale | 214 | 294 | -80 | -27.1 | |
Total equity and liabilities | 298,570 | 312,405 | -13,834 | -4.4 |
Income statement ytd
Consolidated income statement | |||||
Q1-4 2022 | Q1-4 2021 | Change | |||
€m | €m | €m | €m | €m | % |
Gross premiums written | 67,133 | 59,567 | 7,565 | 12.7 | |
1. | Earned premiums | ||||
Gross | 66,391 | 57,597 | 8,794 | 15.3 | |
Ceded | -2,929 | -2,396 | -534 | -22.3 | |
Net | 63,462 | 55,202 | 8,260 | 15.0 | |
2. | Income from technical interest | 3,435 | 5,783 | -2,348 | -40.6 |
3. | Expenses for claims and benefits | ||||
Gross | -49,405 | -46,957 | -2,448 | -5.2 | |
Ceded | 2,448 | 1,574 | 874 | 55.5 | |
Net | -46,957 | -45,383 | -1,574 | -3.5 | |
4. | Operating expenses | ||||
Gross | -16,585 | -14,111 | -2,474 | -17.5 | |
Ceded | 678 | 437 | 241 | 55.1 | |
Net | -15,907 | -13,674 | -2,233 | -16.3 | |
5. | Technical result (1-4) | 4,032 | 1,927 | 2,105 | 109.2 |
6. | Investment result | 4,903 | 7,156 | -2,253 | -31.5 |
Thereof: | |||||
Income from associates and joint ventures accounted | |||||
for using the equity method | 52 | 219 | -167 | -76 | |
7. | Insurance-related investment result | -994 | 1,119 | -2,114 | - |
8. | Other operating income | 1,265 | 1,203 | 62 | 5.1 |
9. | Other operating expenses | -2,190 | -2,106 | -84 | -4.0 |
10. | Deduction of income from technical interest | -3,435 | -5,783 | 2,348 | 40.6 |
11. | Non-technical result (6-10) | -450 | 1,590 | -2,040 | - |
12. | Operating result (5+11) | 3,582 | 3,517 | 65 | 1.8 |
13. | Other non-operating result | -81 | -91 | 9 | 10.3 |
14. | Currency result | 676 | 262 | 414 | 157.9 |
15. | Net finance costs | -179 | -205 | 26 | 12.7 |
16. | Taxes on income | -580 | -552 | -27 | -4.9 |
17. | Consolidated result (12-16) | 3,419 | 2,932 | 487 | 16.6 |
Thereof: | |||||
Attributable to |
|||||
equity holders | 3,432 | 2,933 | 499 | 17.0 | |
Attributable to non-controlling interests | -13 | -1 | -12 | <-1.000,0 | |
€ | € | € | % | ||
Earnings per share | 24.63 | 20.93 | 3.69 | 17.6 |
Income statement Q
Consolidated income statement | |||||
Q4 2022 | Q4 2021 | Change | |||
€m | €m | €m | €m | €m | % |
Gross premiums written | 16,222 | 14,894 | 1,328 | 8.9 | |
1. | Earned premiums | ||||
Gross | 17,732 | 15,430 | 2,302 | 14.9 | |
Ceded | -898 | -594 | -304 | -51.2 | |
Net | 16,834 | 14,836 | 1,998 | 13.5 | |
2. | Income from technical interest | 1,089 | 1,292 | -203 | -15.7 |
3. | Expenses for claims and benefits | ||||
Gross | -12,899 | -11,595 | -1,304 | -11.2 | |
Ceded | 992 | 282 | 710 | 252.0 | |
Net | -11,907 | -11,313 | -594 | -5.3 | |
4. | Operating expenses | ||||
Gross | -4,782 | -4,058 | -724 | -17.8 | |
Ceded | 175 | 90 | 85 | 94.8 | |
Net | -4,607 | -3,968 | -639 | -16.1 | |
5. | Technical result (1-4) | 1,409 | 848 | 561 | 66.2 |
6. | Investment result | 2,041 | 1,425 | 616 | 43.2 |
Thereof: | |||||
Income from associates and | |||||
joint ventures accounted | |||||
for using the equity method | 9 | 86 | -77 | -89.8 | |
7. | Insurance-related investment result | 298 | 286 | 12 | 4.1 |
8. | Other operating income | 397 | 426 | -29 | -6.9 |
9. | Other operating expenses | -671 | -732 | 61 | 8.3 |
10. | Deduction of income from technical interest | -1,089 | -1,292 | 203 | 15.7 |
11. | Non-technical result (6-10) | 976 | 114 | 862 | 758.4 |
12. | Operating result (5+11) | 2,385 | 962 | 1,424 | 148.0 |
13. | Other non-operating result | -52 | -52 | -0 | -0.6 |
14. | Currency result | -672 | 160 | -831 | - |
15. | Net finance costs | -42 | -48 | 6 | 12.8 |
16. | Taxes on income | -104 | -150 | 47 | 31.1 |
17. | Consolidated result (12-16) | 1,516 | 871 | 645 | 74.0 |
Thereof: | |||||
Attributable to |
|||||
equity holders | 1,528 | 868 | 659 | 75.9 | |
Attributable to non-controlling interests | -11 | 3 | -14 | - | |
€ | € | € | % | ||
Earnings per share | 11.05 | 6.20 | 4.85 | 78.3 |
Segment balance sheet
Segment balance sheet | |||||||||||||
Segment assets | |||||||||||||
Reinsurance | ERGO | Total | |||||||||||
Life and Health | Property-casualty | ||||||||||||
Life and health | Property-casualty | International | |||||||||||
€m | |||||||||||||
A. | Intangible assets | 491 | 521 | 2,347 | 2,204 | 141 | 161 | 1,374 | 1,320 | 184 | 172 | 4,537 | 4,379 |
B. | Investments | ||||||||||||
I. | Land and buildings, including buildings on third-party land | 296 | 274 | 3,153 | 3,160 | 3,569 | 3,247 | 203 | 209 | 118 | 138 | 7,340 | 7,029 |
II. | Investments in affiliated companies, associates and joint ventures | 45 | 45 | 4,126 | 1,951 | 509 | 396 | 120 | 110 | 1,105 | 1,133 | 5,904 | 3,635 |
Thereof: | |||||||||||||
Associates and joint ventures accounted | |||||||||||||
for using the equity method | 0 | 0 | 3,893 | 1,714 | 427 | 338 | 59 | 47 | 1,071 | 1,116 | 5,449 | 3,215 | |
III. | Loans | 637 | 659 | 792 | 643 | 45,135 | 47,166 | 1,367 | 1,383 | 617 | 538 | 48,547 | 50,389 |
IV. | Other securities | ||||||||||||
1. Available for sale | 19,941 | 23,269 | 50,537 | 55,785 | 51,572 | 61,315 | 5,468 | 5,742 | 12,869 | 16,356 | 140,388 | 162,468 | |
2. fair value through profit or loss | 318 | 181 | 1,680 | 980 | 1,639 | 1,553 | 181 | 52 | 138 | 184 | 3,956 | 2,950 | |
20,259 | 23,449 | 52,217 | 56,765 | 53,211 | 62,868 | 5,650 | 5,795 | 13,007 | 16,540 | 144,345 | 165,418 | ||
V. | Deposits retained on assumed reinsurance | 4,744 | 5,006 | 4,709 | 3,998 | 8 | 15 | 32 | 8 | 0 | 0 | 9,494 | 9,027 |
VI. | Other investments | 642 | 703 | 2,437 | 2,963 | 929 | 960 | 57 | 68 | 104 | 109 | 4,168 | 4,803 |
26,623 | 30,137 | 67,433 | 69,480 | 103,361 | 114,653 | 7,428 | 7,573 | 14,951 | 18,458 | 219,797 | 240,300 | ||
C. | Insurance-related investments | 2,624 | 2,748 | 1,034 | 861 | 5,239 | 6,045 | 0 | 0 | 2,231 | 2,629 | 11,128 | 12,283 |
D. | Ceded share of technical provisions | 2,506 | 2,607 | 3,190 | 2,651 | 16 | 15 | 187 | 262 | 599 | 564 | 6,498 | 6,099 |
E. | Non-current assets held for sale | 4 | 0 | 119 | 0 | 0 | 78 | 0 | 1 | 325 | 473 | 448 | 552 |
F. | Other segment assets | 21,186 | 20,560 | 21,907 | 16,808 | 8,107 | 7,224 | 2,195 | 1,844 | 2,767 | 2,358 | 56,163 | 48,792 |
Total segment assets | 53,435 | 56,572 | 96,030 | 92,004 | 116,864 | 128,176 | 11,185 | 11,000 | 21,057 | 24,653 | 298,570 | 312,405 | |
Segment equity and liabilities | |||||||||||||
Reinsurance | ERGO | Total | |||||||||||
Life and Health | Property-casualty | ||||||||||||
Life and health | Property-casualty | International | |||||||||||
€m | |||||||||||||
A. | Subordinated liabilities | 1,057 | 1,168 | 3,678 | 3,874 | 0 | 0 | 0 | 0 | 13 | 13 | 4,748 | 5,055 |
B. | Gross technical provisions | ||||||||||||
I. | Unearned premiums | 280 | 295 | 11,179 | 10,392 | 317 | 266 | 644 | 563 | 2,089 | 1,957 | 14,510 | 13,474 |
II. | Provision for future policy benefits | 13,923 | 13,420 | -0 | 0 | 92,032 | 91,203 | 332 | 362 | 9,376 | 9,601 | 115,663 | 114,586 |
III. | Provision for outstanding claims | 11,242 | 11,054 | 66,136 | 59,070 | 3,160 | 2,947 | 5,776 | 5,636 | 3,123 | 2,963 | 89,438 | 81,671 |
IV. | Other underwriting provisions | 196 | 169 | 188 | 318 | 11,014 | 20,248 | 131 | 118 | 35 | 562 | 11,563 | 21,414 |
25,642 | 24,939 | 77,503 | 69,780 | 106,523 | 114,664 | 6,883 | 6,678 | 14,623 | 15,083 | 231,173 | 231,145 | ||
C. | Gross technical provisions | ||||||||||||
for unit-linked life insurance contracts | 0 | -0 | 0 | 0 | 5,555 | 6,375 | 0 | 0 | 2,225 | 2,623 | 7,780 | 8,998 | |
D. | Other provisions | 148 | 186 | 585 | 678 | 826 | 1,922 | 534 | 1,014 | 568 | 1,158 | 2,661 | 4,958 |
E. | Liabilities related to | ||||||||||||
non-current assets held for sale | 0 | 0 | 1 | 0 | 0 | 8 | 0 | 0 | 213 | 286 | 214 | 294 | |
F. | Other segment liabilities | 13,890 | 15,658 | 8,752 | 8,247 | 3,387 | 3,154 | 1,777 | 1,053 | 2,986 | 2,898 | 30,792 | 31,009 |
Total segment liabilities | 40,737 | 41,952 | 90,519 | 82,579 | 116,292 | 126,123 | 9,193 | 8,745 | 20,627 | 22,061 | 277,368 | 281,459 | |
Equity | 21,202 | 30,945 | |||||||||||
Total equity and liabilities | 298,570 | 312,405 |
Segment income statement ytd
Segment income statement | |||||||||||||
Reinsurance | ERGO | Total | |||||||||||
Life and Health | Property-casualty | ||||||||||||
Life and health | Property-casualty | International | |||||||||||
€m | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | |
Gross premiums written | 13,676 | 12,561 | 34,399 | 28,793 | 9,703 | 9,203 | 4,198 | 3,919 | 5,157 | 5,092 | 67,133 | 59,567 | |
1. | Net earned premiums | 12,434 | 11,464 | 32,530 | 26,071 | 9,642 | 9,173 | 3,996 | 3,764 | 4,860 | 4,730 | 63,462 | 55,202 |
2. | Income from technical interest | 706 | 639 | 1,004 | 889 | 1,893 | 3,732 | 42 | 51 | -211 | 472 | 3,435 | 5,783 |
3. | Net expenses for claims and benefits | -10,534 | -10,239 | -21,665 | -17,933 | -9,379 | -11,283 | -2,433 | -2,390 | -2,946 | -3,537 | -46,957 | -45,383 |
4. | Net operating expenses | -2,011 | -1,873 | -9,658 | -8,054 | -1,627 | -1,273 | -1,210 | -1,122 | -1,401 | -1,352 | -15,907 | -13,674 |
5. | Technical result (1-4) | 595 | -9 | 2,211 | 972 | 530 | 349 | 394 | 302 | 301 | 313 | 4,032 | 1,927 |
6. | Investment result | 719 | 860 | 801 | 2,562 | 3,037 | 3,201 | 109 | 209 | 237 | 324 | 4,903 | 7,156 |
7. | Insurance-related investment result | 145 | 75 | 130 | 94 | -880 | 661 | 0 | 0 | -390 | 290 | -994 | 1,119 |
8. | Other operating result | 116 | 58 | -434 | -388 | -322 | -276 | -156 | -107 | -128 | -189 | -924 | -902 |
9. | Deduction of income from technical interest | -706 | -639 | -1,004 | -889 | -1,893 | -3,732 | -42 | -51 | 211 | -472 | -3,435 | -5,783 |
10. | Non-technical result (6-9) | 274 | 353 | -507 | 1,380 | -59 | -147 | -89 | 51 | -70 | -47 | -450 | 1,590 |
11. | Operating result (5+10) | 869 | 344 | 1,704 | 2,352 | 471 | 202 | 306 | 354 | 231 | 266 | 3,582 | 3,517 |
12. | Other non-operating result | -14 | -10 | -20 | -7 | -44 | -46 | -9 | -21 | 6 | -6 | -81 | -91 |
13. | Currency result | 79 | 43 | 362 | 119 | 257 | 77 | -17 | 14 | -4 | 10 | 676 | 262 |
14. | Net finance costs | -26 | -36 | -127 | -135 | 16 | -9 | -7 | -4 | -35 | -20 | -179 | -205 |
15 | Taxes on income | -171 | -16 | -64 | -326 | -214 | -59 | -87 | -109 | -43 | -43 | -580 | -552 |
16. | Consolidated result (11-15) | 737 | 325 | 1,856 | 2,003 | 485 | 164 | 185 | 234 | 155 | 207 | 3,419 | 2,932 |
Segment income statement Q
Segment income statement | |||||||||||||
Reinsurance | ERGO | Total | |||||||||||
Life and Health | Property-casualty | ||||||||||||
Life and health | Property-casualty | International | |||||||||||
€m | Q4 2022 | Q4 2021 | Q4 2022 | Q4 2021 | Q4 2022 | Q4 2021 | Q4 2022 | Q4 2021 | Q4 2022 | Q4 2021 | Q4 2022 | Q4 2021 | |
Gross premiums written | 3,548 | 3,196 | 8,168 | 7,311 | 2,400 | 2,366 | 813 | 769 | 1,293 | 1,253 | 16,222 | 14,894 | |
1. | Net earned premiums | 3,174 | 2,962 | 8,931 | 7,325 | 2,437 | 2,372 | 1,045 | 985 | 1,247 | 1,192 | 16,834 | 14,836 |
2. | Income from technical interest | 191 | 170 | 257 | 243 | 498 | 745 | 10 | 13 | 134 | 122 | 1,089 | 1,292 |
3. | Net expenses for claims and benefits | -2,566 | -2,619 | -5,529 | -4,596 | -2,236 | -2,708 | -622 | -551 | -954 | -839 | -11,907 | -11,313 |
4. | Net operating expenses | -532 | -481 | -2,908 | -2,473 | -447 | -345 | -339 | -300 | -382 | -368 | -4,607 | -3,968 |
5. | Technical result (1-4) | 267 | 32 | 751 | 499 | 252 | 64 | 94 | 146 | 45 | 108 | 1,409 | 848 |
6. | Investment result | 320 | 239 | 1,112 | 654 | 478 | 437 | 39 | 26 | 93 | 70 | 2,041 | 1,425 |
7. | Insurance-related investment result | 43 | 2 | 18 | -24 | 148 | 222 | 0 | 0 | 89 | 86 | 298 | 286 |
8. | Other operating result | 43 | 6 | -135 | -143 | -92 | -77 | -33 | -18 | -58 | -73 | -274 | -306 |
9. | Deduction of income from technical interest | -191 | -170 | -257 | -243 | -498 | -745 | -10 | -13 | -134 | -122 | -1,089 | -1,292 |
10. | Non-technical result (6-9) | 215 | 77 | 738 | 244 | 35 | -163 | -4 | -5 | -10 | -39 | 976 | 114 |
11. | Operating result (5+10) | 482 | 108 | 1,489 | 743 | 287 | -99 | 91 | 141 | 36 | 68 | 2,385 | 962 |
12. | Other non-operating result | -9 | -9 | -14 | 8 | -32 | -34 | -2 | -12 | 4 | -5 | -52 | -52 |
13. | Currency result | -97 | 22 | -262 | 50 | -274 | 78 | -30 | 3 | -9 | 8 | -672 | 160 |
14. | Net finance costs | -5 | -8 | -29 | -37 | 7 | 1 | -4 | 0 | -11 | -4 | -42 | -48 |
15 | Taxes on income | -126 | -27 | -37 | -116 | 49 | 13 | 6 | -25 | 4 | 6 | -104 | -150 |
16. | Consolidated result (11-15) | 245 | 86 | 1,148 | 648 | 38 | -42 | 62 | 106 | 24 | 73 | 1,516 | 871 |
Combined ratio
Notes on determining the combined ratio | |||||||
Reinsurance | ERGO | ||||||
Property-casualty | Property-casualty |
Property-casualty International1 | |||||
€m | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | Q1-4 2022 | Q1-4 2021 | |
Net earned premiums | 32,530 | 26,071 | 3,996 | 3,764 | 3,600 | 3,467 | |
Net expenses for claims and benefits | -21,665 | -17,933 | -2,433 | -2,390 | -2,270 | -2,181 | |
Net operating expenses | -9,658 | -8,054 | -1,210 | -1,122 | -1,125 | -1,056 | |
Loss-ratio calculation adjustments | 17 | 13 | 22 | 33 | 1 | 18 | |
Fire brigade tax and other expenses | 32 | 23 | 20 | 18 | 26 | 24 | |
Expenses for premium refunds | 1 | 0 | 29 | 30 | 1 | -1 | |
Other underwriting income | -15 | -9 | -3 | -3 | -11 | -11 | |
Change in remaining technical provisions and other underwriting expenses | -1 | -1 | -24 | -12 | -15 | 6 | |
Adjusted net expenses for claims and benefits | -21,647 | -17,920 | -2,410 | -2,357 | -2,269 | -2,163 | |
Loss ratio | % | 66.5 | 68.7 | 60.3 | 62.6 | 63.0 | 62.4 |
Combined ratio | % | 96.2 | 99.6 | 90.6 | 92.4 | 94.3 | 92.9 |
1 Property-casualty business and short-term health insurance not conducted like life insurance. |
RoE
Notes on determining the retuon equity (RoE) | ||||||
Reinsurance | ERGO | Total | ||||
€m | 31.12.20211 | 31.12.20211 | ||||
Segment assets | 149,464 | 148,576 | 149,106 | 163,828 | 298,570 | 312,405 |
Segment liabilites | 131,256 | 124,530 | 146,112 | 156,929 | 277,368 | 281,459 |
Adjustments used in the calculation of equity | ||||||
Unrealised gains and losses, currency translation reserve, remeasurement gains/losses from cash flow hedges | -2,043 | 4,759 | -3,162 | 1,883 | -5,205 | 6,642 |
Adjustment item for material asset transfers between reinsurance and ERGO | 976 | 1,020 | -976 | -1,020 | 0 | 0 |
Adjusted equity | 19,275 | 18,267 | 7,132 | 6,036 | 26,407 | 24,303 |
Q1-4 2022 | Q1-4 2022 | Q1-4 2022 | ||||
Average adjusted equity | 18,771 | 6,584 | 25,355 | |||
Consolidated result | 2,593 | 826 | 3,419 | |||
Retuon equity (RoE) | % | 13.8 | 12.5 | 13.5 | ||
1 | Since Q1 2022, receivables and liabilities in connection with intra-Group loans have been presented in an unconsolidated form and thus aligned with the presentation of income and expenses in connection with intra-Group loans. The previous year's figures in the segment balance sheet have been adjusted accordingly, which resulted in the RoE for the previous year decreasing from 13.5% to 13.4% in reinsurance. | |||||
Notes on determining the retuon equity (RoE) | ||||||
Reinsurance | ERGO | Total | ||||
€m | 31.12.20211 | 31.12.20211 | ||||
Segment assets | 148,576 | 133,892 | 163,828 | 164,055 | 312,405 | 297,946 |
Segment liabilites | 124,530 | 112,138 | 156,929 | 155,815 | 281,459 | 267,952 |
Adjustments used in the calculation of equity | ||||||
Unrealised gains and losses, currency translation reserve, remeasurement gains/losses from cash flow hedges | 4,759 | 4,994 | 1,883 | 2,689 | 6,642 | 7,683 |
Adjustment item for material asset transfers between reinsurance and ERGO | 1,020 | 410 | -1,020 | -410 | 0 | 0 |
Adjusted equity | 18,267 | 16,350 | 6,036 | 5,961 | 24,303 | 22,311 |
Q1-4 2021 | Q1-4 2021 | Q1-4 2021 | ||||
Average adjusted equity | 17,308 | 5,999 | 23,307 | |||
Consolidated result | 2,328 | 605 | 2,932 | |||
Retuon equity (RoE) | % | 13.4 | 10.1 | 12.6 | ||
1 | Since Q1 2022, receivables and liabilities in connection with intra-Group loans have been presented in an unconsolidated form and thus aligned with the presentation of income and expenses in connection with intra-Group loans. The figures for 2021 in the segment balance sheet have been adjusted accordingly, which resulted in the RoE for 2021 decreasing from 13.5% to 13.4% in reinsurance. |
Portfolio duration
Portfolio-Duration1 | Assets | Liabilities | ||
Reinsurance | 4.8 | 6.0 | 5.0 | 6.4 |
ERGO | 7.6 | 9.6 | 6.9 | 9.3 |
6.5 | 8.3 | 6.3 | 8.4 | |
DVO11,2 | Assets | Liabilities | ||
Reinsurance | 34 | 46 | 27 | 38 |
ERGO | 81 | 125 | 75 | 125 |
114 | 171 | 102 | 163 | |
1 Fair values as at |
||||
2 Market-value change due to a parallel downward shift in yield curve by one basis point, considering the portfolio size of assets and liabilities (pre-tax). Negative net DV01 means rising interest rates are beneficial. |
Sensitivities
Sensitivities to interest rates, spreads and equities1 | ||||
Sensitivity to risk-free interest in €bn (change in basis points) | -50bps | -25bps | +50bps | +100bps |
Change in market value, gross | 5.8 | 2.9 | -5.4 | -10.3 |
Change in on-balance-sheet reserves, net | 1.8 | 0.9 | -1.7 | -3.2 |
Change in off-balance-sheet reserves, net | 0.2 | 0.1 | -0.2 | -0.4 |
P&L (investment result), gross | 0.1 | 0.0 | -0.1 | -0.2 |
P&L, net | 0.0 | 0.0 | 0.0 | -0.1 |
Sensitivity to spread2 in €bn (change in basis points) | +50bps | +100bps | ||
Change in market value, gross | 0.0 | 0.0 | -3.5 | -6.8 |
Change in on-balance-sheet reserves, net | 0.0 | 0.0 | -0.9 | -1.8 |
Change in off-balance-sheet reserves, net | 0.0 | 0.0 | -0.2 | -0.3 |
P&L (investment result), gross | 0.0 | 0.0 | 0.0 | 0.0 |
P&L, net | 0.0 | 0.0 | 0.0 | 0.1 |
Sensitivity to share prices3 in €bn (change in %) | -30% | -10% | +10% | +30% |
Change in market value, gross | -1.2 | -0.5 | 0.5 | 1.5 |
Change in on-balance-sheet reserves, net | 0.0 | 0.1 | 0.4 | 1.2 |
P&L (investment result), gross | -1.2 | -0.6 | -0.4 | -1.2 |
P&L, net | -0.9 | -0.4 | 0.0 | -0.1 |
1 Rough calculation with limited reliability assuming unchanged portfolio as at |
||||
2 Sensitivities to changes of spreads are calculated for every category of fixed income portfolio, except government securities with |
||||
3 Sensitivities to change in share prices are calculated for listed shares only; assumptions: equity impairments as soon as market value drops below acquisition cost and best-estimate calculation of hedging impact. |
On-&off-balance sheet reserves
On- and off-balance-sheet reserves | |||
p | |||
€m | Delta Q4 | ||
Market value of investments | 228,298 | 223,471 | -4,827 |
Total reserves | -8,597 | -9,228 | -631 |
On-balance-sheet reserves | |||
Fixed-interest securities | -16,037 | -15,015 | 1,022 |
Non-fixed-interest securities | 2,759 | 1,950 | -809 |
Other on-balance-sheet reserves1 | 196 | 163 | -32 |
Subtotal | -13,082 | -12,902 | 180 |
Off-balance-sheet reserves | |||
Real estate2 | 6,057 | 5,753 | -305 |
Loans3 | -4,109 | -4,956 | -847 |
Associates | 2,537 | 2,878 | 341 |
Subtotal | 4,485 | 3,674 | -811 |
Reserve ratio | -3.8% | -4.1% | -0.4%-pts. |
1 Unrealised gains/losses from unconsolidated affiliated companies, valuation at equity and cash-flow hedging. 2 Excluding reserves from owner-occupied property. 3 Excluding insurance-related loans. |
On-&off bs reserves (gross&net)
On- and off-balance-sheet reserves (gross/net) | ||||
On-balance-sheet reserves | Off-balance-sheet reserves1 | |||
€m | ||||
Total reserves (gross) | -12,902 | 13,172 | 3,674 | 17,185 |
Provision deferred premium refunds | 4,479 | -5,409 | 1,758 | -8,115 |
Deferred tax | 1,831 | -1,848 | -1,335 | -2,496 |
Minority interests | 0 | -10 | ||
Consolidation and currency effects | -366 | -127 | ||
Shareholders' stake | -6,958 | 5,778 | 4,098 | 6,574 |
1 Excluding reserves for owner-occupied property and insurance-related loans. |
Attachments
Disclaimer
Full Year 2022 Earnings – Strong results and continued execution
Northwestern Mutual posts record annual revenue
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News